1. Home
  2. GD vs SNY Comparison

GD vs SNY Comparison

Compare GD & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo General Dynamics Corporation

GD

General Dynamics Corporation

HOLD

Current Price

$344.60

Market Cap

93.8B

Sector

Industrials

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$42.34

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GD
SNY
Founded
2019
1994
Country
United States
France
Employees
N/A
74846
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.8B
104.5B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
GD
SNY
Price
$344.60
$42.34
Analyst Decision
Buy
Buy
Analyst Count
15
5
Target Price
$375.33
$58.00
AVG Volume (30 Days)
1.2M
3.5M
Earning Date
04-29-2026
04-23-2026
Dividend Yield
1.77%
3.47%
EPS Growth
13.35
N/A
EPS
15.45
N/A
Revenue
$52,550,000,000.00
N/A
Revenue This Year
$7.38
$3.49
Revenue Next Year
$4.50
$6.10
P/E Ratio
$22.27
$6.14
Revenue Growth
10.13
N/A
52 Week Low
$289.40
$40.89
52 Week High
$369.70
$52.68

Technical Indicators

Market Signals
Indicator
GD
SNY
Relative Strength Index (RSI) 47.79 43.39
Support Level $343.80 $42.30
Resistance Level $350.69 $48.76
Average True Range (ATR) 8.58 0.73
MACD -1.23 -0.15
Stochastic Oscillator 18.91 35.86

Price Performance

Historical Comparison
GD
SNY

About GD General Dynamics Corporation

General Dynamics is a defense contractor and business jet manufacturer. The firm's segments are aerospace, marine, combat systems, and technologies. General Dynamics' aerospace segment manufactures Gulfstream business jets and operates a global aircraft servicing operation. Combat systems produces land-based combat vehicles such as the M1 Abrams tank and Stryker armored personnel carrier, as well as munitions. The marine segment builds and services nuclear-powered submarines, destroyers, and Navy support ships. The technologies segment contains two main units: an IT business that primarily serves the government market and a mission systems business focusing on electronics that provide command, control, computing, intelligence, surveillance, and reconnaissance capabilities to the military.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: